ライフサイエンスコーパス: continuous renal replacement therapy

1 Critically ill adults requiring continuous renal replacement therapy.

2 r blood flow rate influences circuit life in continuous renal replacement therapy.

3 n of regional citrate anticoagulation during continuous renal replacement therapy.

4 ensity score for the likelihood of receiving continuous renal replacement therapy.

5 blood flow rates of 250 or 150 mL/min during continuous renal replacement therapy.

6 s parameters and then compared with forms of continuous renal replacement therapy.

7 ng adults with acute kidney injury receiving continuous renal replacement therapy.

8 Continuous renal replacement therapy.

9 ation of excess fluid that can be removed by continuous renal replacement therapy.

10 atment sessions may use hemodialysis (1D) or continuous renal replacement therapy (1D).

11 ive mechanical ventilation; 5 (19%) received continuous renal-replacement therapy; 22 (81%) received

12 Of the children managed with continuous renal replacement therapy, 26 (58%) survived:

13 n anticoagulation has remained a problem for continuous renal replacement therapies and intermittent

14 ations existed between effluent flow rate in continuous renal replacement therapy and extracorporeal

15 We report the use of continuous renal replacement therapy and rituximab in a

16 e to describe feeding practices in pediatric continuous renal replacement therapy and to evaluate fac

17 ntilation, pulmonary artery catheterization, continuous renal replacement therapy, and permanent card

18 Patients receiving regional continuous renal replacement therapy anticoagulation wit

19 gistry suggests that early intervention with continuous renal replacement therapy, as well as goal-di

20 Continuous renal replacement therapy can be used success

21 citrate and calcium anticoagulation prolongs continuous renal replacement therapy circuit life compar

22 mized 212 subjects who were treated with 857 continuous renal replacement therapy circuits (median 2

23 Based on four groups of continuous renal replacement therapy commencement ([grou

24 time between RIFLE-I acute kidney injury and continuous renal replacement therapy commencement was 17

25 d Level Replacement Therapy Study (proxy for continuous renal replacement therapy commencement) was t

26 Continuous renal replacement therapies (CRRT) often are

27 Continuous renal replacement therapy (CRRT) benefits pat

28 Continuous renal replacement therapy (CRRT) has become a

29 Once continuous renal replacement therapy (CRRT) is initiated

30 Continuous renal replacement therapy (CRRT) is the most

31 Continuous renal replacement therapy (CRRT) machines are

32 patients with ARF compared with conventional continuous renal replacement therapy (CRRT), a Phase II,

33 By continuous renal replacement therapy day 5, median prote

34 The degree of fluid overload at continuous renal replacement therapy discontinuation is

35 Median fluid overload at continuous renal replacement therapy discontinuation was

36 of illness, the change in fluid overload at continuous renal replacement therapy discontinuation was

37 inary results to indicate the earlier use of continuous renal replacement therapy for both renal dysf

38 oreal life support and patients initiated on continuous renal replacement therapy for indications oth

39 Children who received continuous renal replacement therapy for management of a

40 Time to initiate continuous renal replacement therapy from PICU admission

41 Although much of the outcome data for continuous renal replacement therapy has been retrospect

42 ith intermittent hemodialysis, initiation of continuous renal replacement therapy in critically ill a

43 verload frequently necessitate initiation of continuous renal replacement therapy in critically ill p

44 The guidelines for continuous renal replacement therapy in pediatric acute

45 The use of continuous renal replacement therapy in pediatric critic

46 ngs suggest a role for earlier initiation of continuous renal replacement therapy in this population,

47 on, extracorporeal membrane oxygenation, and continuous renal replacement therapy, in addition to pla

48 ate an association between fluid overload at continuous renal replacement therapy initiation and mort

49 , severity of illness, and fluid overload at continuous renal replacement therapy initiation found th

50 In pediatric patients, fluid overload at continuous renal replacement therapy initiation is assoc

51 Median fluid overload at continuous renal replacement therapy initiation was sign

52 rapy initiation found that fluid overload at continuous renal replacement therapy initiation was the

53 Mean protein and caloric prescriptions at continuous renal replacement therapy initiation were 1.3

54 fter adjusting for percent fluid overload at continuous renal replacement therapy initiation, age, an

55 ze the association between fluid overload at continuous renal replacement therapy initiation, fluid r

56 Fluid overload, indication for continuous renal replacement therapy initiation, severit

57 hronologically as time from ICU admission to continuous renal replacement therapy initiation.

58 of such children who may benefit from early continuous renal replacement therapy initiation.

59 he possible relevance of biocompatibility in continuous renal replacement therapies is emphasized.

60 Continuous renal replacement therapy is valuable for sur

61 in practice to initiate early and high-dose continuous renal replacement therapy led to increased su

62 emodialysis is preferred initially (1D), but continuous renal replacement therapies may be considered

63 Protein prescription in pediatric continuous renal replacement therapy may be inadequate.

64 onferring greater hemodynamic stability; yet continuous renal replacement therapy may not enhance pat

65 with conventional intermittent hemodialysis, continuous renal replacement therapy may promote kidney

66 this time, center-based results suggest that continuous renal replacement therapy may prove beneficia

67 In patients with sepsis and septic shock, continuous renal replacement therapy offers a means for

68 ermine the effect of timing of initiation of continuous renal replacement therapy on ICU mortality in

69 We performed continuous renal replacement therapy on patients.

70 cular access type, length, site, and mode of continuous renal replacement therapy or international no

71 inclusion criteria and 45 of these received continuous renal replacement therapy prior to transplant

72 We identified 2,315 continuous renal replacement therapy recipients of whom

73 Continuous renal replacement therapy recipients were mat

74 r, early data from the prospective pediatric continuous renal replacement therapy registry suggests t

75 ement Therapy Study, earlier commencement of continuous renal replacement therapy relative to RIFLE-I

76 optimal regimen of intermittent dialysis or continuous renal replacement therapy remains to be deter

77 Continuous renal replacement therapy should be considere

78 o did not receive a liver transplant, use of continuous renal replacement therapy significantly impro

79 hyperammonemia by 48 hours after initiating continuous renal replacement therapy significantly impro

80 and 189.3 and 35.6 mL/min, respectively, in continuous renal replacement therapy studies.

81 eplacement therapies including hemodialysis, continuous renal replacement therapy, the bioartificial

82 ent therapy initiation, fluid removal during continuous renal replacement therapy, the kinetics of fl

83 was determined to be similar or higher than continuous renal replacement therapy therapies.

84 en patients on the basis of the intensity of continuous renal replacement therapy; this effect may ha

85 otein and caloric prescription and number of continuous renal replacement therapy treatment days (p <

86 ine whether bacteria could be recovered from continuous renal replacement therapy ultrafiltrates of c

87 rms of length of stay, ventilator usage, and continuous renal replacement therapy usage compared with

88 Continuous renal replacement therapy usage, defined as p

89 Continuous renal replacement therapy using blood flow ra

90 Initial receipt of continuous renal replacement therapy versus intermittent

91 lower among patients who initially received continuous renal replacement therapy versus intermittent

92 Earlier initiation of continuous renal replacement therapy was associated with

93 Our objective was to determine whether continuous renal replacement therapy was associated with

94 up 4]: >/= 46.0 hr), earlier commencement of continuous renal replacement therapy was not associated

95 In critically ill patients receiving continuous renal replacement therapy, we aimed to assess

96 with severe acute kidney injury treated with continuous renal replacement therapy, we found no associ

97 mal protein and caloric prescriptions during continuous renal replacement therapy were 2.0 +/- 1.5 g/

98 al protein and caloric prescription while on continuous renal replacement therapy were younger age, i

99 rations in critically ill patients receiving continuous renal replacement therapy, which did not only

100 ty in a large pediatric population receiving continuous renal replacement therapy while on extracorpo

101 Continuous renal replacement therapy without anticoagula